Clinical trial
Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose…
NCT00413335 · Yale University, Other · Completed
Key facts
| NCT number | NCT00413335 |
|---|---|
| Title | Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth |
| Official title | Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth |
| Lead sponsor | Yale University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Obesity, Impaired Glucose Tolerance, Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Rosiglitazone, Placebo |
| Enrollment | 21 |
| Start date | Nov 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Dec 19, 2006 |
| Last update posted | Jul 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: